New-Generation Anticoagulants: The Low Molecular Weight Heparins
- 1 December 1999
- journal article
- review article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 34 (6) , 768-779
- https://doi.org/10.1016/s0196-0644(99)70104-6
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacology of the low-molecular-weight heparinsAmerican Heart Journal, 1998
- Low-molecular-weight heparin for the treatment of venous thromboembolismAmerican Heart Journal, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1995
- TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparinThrombosis Research, 1995
- HeparinNew England Journal of Medicine, 1991
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Hemorrhagic Complications of Anticoagulant TherapySeminars in Thrombosis and Hemostasis, 1986
- Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationThrombosis Research, 1985
- Audit of control of heparin treatment.BMJ, 1985